Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the mass balance, pharmacokinetics (PK), and safety of
belinostat following IV administration in patients with a recurrent or progressive
malignancy.